These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29987267)

  • 21. Identification of DEAD-box RNA helicase 6 (DDX6) as a cellular modulator of vascular endothelial growth factor expression under hypoxia.
    de Vries S; Naarmann-de Vries IS; Urlaub H; Lue H; Bernhagen J; Ostareck DH; Ostareck-Lederer A
    J Biol Chem; 2013 Feb; 288(8):5815-27. PubMed ID: 23293030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Twist1 correlates with poor differentiation and progression in gastric adenocarcinoma via elevation of FGFR2 expression.
    Zhu DY; Guo QS; Li YL; Cui B; Guo J; Liu JX; Li P
    World J Gastroenterol; 2014 Dec; 20(48):18306-15. PubMed ID: 25561797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The RNA Helicase DDX6 Controls Cellular Plasticity by Modulating P-Body Homeostasis.
    Di Stefano B; Luo EC; Haggerty C; Aigner S; Charlton J; Brumbaugh J; Ji F; Rabano Jiménez I; Clowers KJ; Huebner AJ; Clement K; Lipchina I; de Kort MAC; Anselmo A; Pulice J; Gerli MFM; Gu H; Gygi SP; Sadreyev RI; Meissner A; Yeo GW; Hochedlinger K
    Cell Stem Cell; 2019 Nov; 25(5):622-638.e13. PubMed ID: 31588046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive Protein Interactome Analysis of a Key RNA Helicase: Detection of Novel Stress Granule Proteins.
    Bish R; Cuevas-Polo N; Cheng Z; Hambardzumyan D; Munschauer M; Landthaler M; Vogel C
    Biomolecules; 2015 Jul; 5(3):1441-66. PubMed ID: 26184334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A reciprocal regulatory circuit between CD44 and FGFR2 via c-myc controls gastric cancer cell growth.
    Park J; Kim SY; Kim HJ; Kim KM; Choi EY; Kang MS
    Oncotarget; 2016 May; 7(19):28670-83. PubMed ID: 27107424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human DDX6 regulates translation and decay of inefficiently translated mRNAs.
    Weber R; Chang CT
    Elife; 2024 Jul; 13():. PubMed ID: 38989862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR‑494 inhibits cancer‑initiating cell phenotypes and reverses resistance to lapatinib by downregulating FGFR2 in HER2‑positive gastric cancer.
    Yu Y; Yu X; Liu H; Song Q; Yang Y
    Int J Mol Med; 2018 Aug; 42(2):998-1007. PubMed ID: 29786108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rare De Novo Missense Variants in RNA Helicase DDX6 Cause Intellectual Disability and Dysmorphic Features and Lead to P-Body Defects and RNA Dysregulation.
    Balak C; Benard M; Schaefer E; Iqbal S; Ramsey K; Ernoult-Lange M; Mattioli F; Llaci L; Geoffroy V; Courel M; Naymik M; Bachman KK; Pfundt R; Rump P; Ter Beest J; Wentzensen IM; Monaghan KG; McWalter K; Richholt R; Le Béchec A; Jepsen W; De Both M; Belnap N; Boland A; Piras IS; Deleuze JF; Szelinger S; Dollfus H; Chelly J; Muller J; Campbell A; Lal D; Rangasamy S; Mandel JL; Narayanan V; Huentelman M; Weil D; Piton A
    Am J Hum Genet; 2019 Sep; 105(3):509-525. PubMed ID: 31422817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FGF18-FGFR2 signaling triggers the activation of c-Jun-YAP1 axis to promote carcinogenesis in a subgroup of gastric cancer patients and indicates translational potential.
    Zhang J; Wong CC; Leung KT; Wu F; Zhou Y; Tong JHM; Chan RCK; Li H; Wang Y; Yan H; Liu L; Wu WKK; Chan MWY; Cheng ASL; Yu J; Wong N; Lo KW; To KF; Kang W
    Oncogene; 2020 Oct; 39(43):6647-6663. PubMed ID: 32934314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study.
    Su X; Zhan P; Gavine PR; Morgan S; Womack C; Ni X; Shen D; Bang YJ; Im SA; Ho Kim W; Jung EJ; Grabsch HI; Kilgour E
    Br J Cancer; 2014 Feb; 110(4):967-75. PubMed ID: 24457912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DDX6 and its orthologs as modulators of cellular and viral RNA expression.
    Ostareck DH; Naarmann-de Vries IS; Ostareck-Lederer A
    Wiley Interdiscip Rev RNA; 2014; 5(5):659-78. PubMed ID: 24788243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DDX6 Represses Aberrant Activation of Interferon-Stimulated Genes.
    Lumb JH; Li Q; Popov LM; Ding S; Keith MT; Merrill BD; Greenberg HB; Li JB; Carette JE
    Cell Rep; 2017 Jul; 20(4):819-831. PubMed ID: 28746868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of two dead box genes (DDX1 and DDX6) is independent of that of MYCN in human neuroblastoma cell lines.
    Akiyama K; Akao Y; Yokoyama M; Nakagawa Y; Noguchi T; Yagi K; Nishi Y
    Biochem Mol Biol Int; 1999 Apr; 47(4):563-8. PubMed ID: 10319407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple receptor tyrosine kinase activation attenuates therapeutic efficacy of the fibroblast growth factor receptor 2 inhibitor AZD4547 in FGFR2 amplified gastric cancer.
    Chang J; Wang S; Zhang Z; Liu X; Wu Z; Geng R; Ge X; Dai C; Liu R; Zhang Q; Li W; Li J
    Oncotarget; 2015 Feb; 6(4):2009-22. PubMed ID: 25576915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DDX6 Helicase Behavior and Protein Partners in Human Adipose Tissue-Derived Stem Cells during Early Adipogenesis and Osteogenesis.
    Marcon BH; Rebelatto CK; Cofré AR; Dallagiovanna B; Correa A
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The DEAD-box RNA helicase DDX6 is required for efficient encapsidation of a retroviral genome.
    Yu SF; Lujan P; Jackson DL; Emerman M; Linial ML
    PLoS Pathog; 2011 Oct; 7(10):e1002303. PubMed ID: 22022269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural insight of human DEAD-box protein rck/p54 into its substrate recognition with conformational changes.
    Matsui T; Hogetsu K; Usukura J; Sato T; Kumasaka T; Akao Y; Tanaka N
    Genes Cells; 2006 Apr; 11(4):439-52. PubMed ID: 16611246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Fibroblast Growth Factor Receptor 2 Expression, Heterogeneity and Clinical Significance in Gastric Cancer.
    Han N; Kim MA; Lee HS; Kim WH
    Pathobiology; 2015; 82(6):269-79. PubMed ID: 26516773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffuse-type gastric cancer cells switch their driver pathways from FGFR2 signaling to SDF1/CXCR4 axis in hypoxic tumor microenvironments.
    Kinoshita H; Yashiro M; Fukuoka T; Hasegawa T; Morisaki T; Kasashima H; Masuda G; Noda S; Hirakawa K
    Carcinogenesis; 2015 Dec; 36(12):1511-20. PubMed ID: 26385890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. H19 functions as a competing endogenous RNA to regulate human epidermal growth factor receptor expression by sequestering let‑7c in gastric cancer.
    Wei Y; Liu Z; Fang J
    Mol Med Rep; 2018 Feb; 17(2):2600-2606. PubMed ID: 29207111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.